Entera Bio Stock Price Prediction

ENTX Stock  USD 1.60  0.02  1.27%   
At this time, the RSI of Entera Bio's share price is approaching 36 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Entera Bio, making its price go up or down.

Momentum 36

 Sell Extended

 
Oversold
 
Overbought
The successful prediction of Entera Bio's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Entera Bio, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Entera Bio's stock price prediction:
EPS Estimate Next Quarter
(0.11)
EPS Estimate Current Year
(0.28)
EPS Estimate Next Year
(0.68)
Wall Street Target Price
10
EPS Estimate Current Quarter
(0.09)
Using Entera Bio hype-based prediction, you can estimate the value of Entera Bio from the perspective of Entera Bio response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Entera Bio using Entera Bio's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Entera using crowd psychology based on the activity and movement of Entera Bio's stock price.

Entera Bio Implied Volatility

    
  0.26  
Entera Bio's implied volatility exposes the market's sentiment of Entera Bio stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Entera Bio's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Entera Bio stock will not fluctuate a lot when Entera Bio's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Entera Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying Entera because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Entera Bio after-hype prediction price

    
  USD 1.6  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Entera Bio Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Entera Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.081.546.43
Details
Naive
Forecast
LowNextHigh
0.031.736.61
Details
1 Analysts
Consensus
LowTargetHigh
9.1010.0011.10
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.11-0.11-0.11
Details

Entera Bio After-Hype Price Density Analysis

As far as predicting the price of Entera Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Entera Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Entera Bio, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Entera Bio Estimiated After-Hype Price Volatility

In the context of predicting Entera Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Entera Bio's historical news coverage. Entera Bio's after-hype downside and upside margins for the prediction period are 0.08 and 6.49, respectively. We have considered Entera Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
1.60
1.60
After-hype Price
6.49
Upside
Entera Bio is dangerous at this time. Analysis and calculation of next after-hype price of Entera Bio is based on 3 months time horizon.

Entera Bio Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Entera Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Entera Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Entera Bio, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.63 
4.80
  0.06 
  0.53 
20 Events / Month
7 Events / Month
In about 20 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
1.60
1.60
0.00 
4,800  
Notes

Entera Bio Hype Timeline

Entera Bio is currently traded for 1.60. The entity has historical hype elasticity of 0.06, and average elasticity to hype of competition of -0.53. Entera is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at -0.63%. %. The volatility of related hype on Entera Bio is about 568.72%, with the expected price after the next announcement by competition of 1.07. About 25.0% of the company shares are held by company insiders. The book value of Entera Bio was currently reported as 0.33. The company recorded a loss per share of 0.24. Entera Bio had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 20 days.
Check out Entera Bio Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.

Entera Bio Related Hype Analysis

Having access to credible news sources related to Entera Bio's direct competition is more important than ever and may enhance your ability to predict Entera Bio's future price movements. Getting to know how Entera Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Entera Bio may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ANIXAnixa Biosciences(0.06)19 per month 0.00 (0.06) 8.98 (6.51) 40.89 
VTGNVistaGen Therapeutics(0.02)6 per month 0.00 (0.14) 7.61 (12.80) 96.59 
IRDOpus Genetics 0.01 10 per month 3.57  0.09  6.70 (6.10) 26.50 
SEERSeer Inc 0.01 8 per month 0.00 (0.14) 3.41 (3.06) 9.98 
HURATuHURA Biosciences(0.05)12 per month 0.00 (0.25) 7.73 (10.53) 50.34 
ABOSAcumen Pharmaceuticals 0.02 3 per month 4.63 (0.01) 9.94 (7.18) 25.06 
MCRBSeres Therapeutics(8.28)8 per month 0.00 (0.02) 9.13 (7.64) 54.10 
SPROSpero Therapeutics 0.04 5 per month 2.66  0.02  3.64 (5.04) 13.07 
AGENAgenus Inc(0.04)13 per month 0.00 (0.1) 6.63 (6.05) 30.06 
INOInovio Pharmaceuticals(0.07)24 per month 0.00 (0.13) 6.87 (6.80) 36.52 

Entera Bio Additional Predictive Modules

Most predictive techniques to examine Entera price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Entera using various technical indicators. When you analyze Entera charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Entera Bio Predictive Indicators

The successful prediction of Entera Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Entera Bio, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Entera Bio based on analysis of Entera Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Entera Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Entera Bio's related companies.
 2023 2025 2026 (projected)
Interest Debt Per Share0.01340.0083080.007893
Revenue Per Share0.0048070.0055290.005252

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Entera Stock Analysis

When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.